ABSTRACT
Introduction
Congenital diaphragmatic hernia (CDH) is one of the most challenging and perplexing malformations, associated with a high mortality (36% based on the CDH registry). (1) As one of the most common and serious congenital disorders in the neonatal intensive care unit (NICU), CDH has been the focus of research programs from dozens of investigative teams internationally. The estimated incidence of CDH was 1 per 2,000-5,000 live births and affects approximately 1,100 infants annually in the USA, (2) CDH occurs in between 1 in 2,500 to 1 in 4,000 live births. (3, 4) Many initial clinical characteristics associated with poor outcome in infants with CDH have been identified as risk factors and they include birth weight, (1) the size of the diaphragmatic defect, (5,6) a low 5-minute Apgar score, (1, 7, 8) prematurity, (7) an air leak (7) and the presence of other structural defects or chromosomal abnormalities. (9) Moreover, in cases of isolated CDH, pulmonary hypoplasia and associated persistent pulmonary hypertension of newborn (PPHN) are the main causes of death. (10) The key to successful postnatal management of CDH is the use of mechanical ventilation and/or extracorporeal membrane oxygenation (ECMO) to manage the pulmonary alveolar hypoplasia and the PPHN. Current management strategies consist of preoperative stabilization and delayed repair. (11) However, ECMO facilities are not available in most Asian countries. Various other treatment strategies were developed by different centers to improve outcome. Many centers are now using high frequency oscillatory ventilation (HFOV) as an alternative to conventional ventilation because this will reduce the amount of ventilator induced lung injury. HFOV and inhaled nitric oxide (iNO) were first made available at our center in the late 1990s, but we found the overall mortality for neonates with CDH still high, and thus we conducted this retrospective study to determine the risk factors and outcomes of CDH and to identify the independent predictors for mortality in our NICU. However, the relative rarity and clinical variability of CDH makes it difficult to conduct well-designed clinical studies at a single institution and to establish the most suitable treatment. The epidemiology and outcomes of CDH are well described in developed countries, (2-4) but few data exist for developing countries, particularly with respect to risk factors and outcomes such as morbidity, mortality, and hospital length of stay. Recently, Ruano R et al. (9) described the perinatal results of CDH among neonates in Brazil and Rohana J et al. (8) reported that low Apgar scores and high oxygenation index (OI) were associated with poor outcome in infants with CDH. However, there are limited data with respect to the risk factors and outcomes specific to CDH from China. We summarized data from the last 10 years and included cases with CDH referred to a tertiary institute, to determine: 1. the survival rate of CDH, 2. the early outcomes of CDH after surgery, and 3. risk factors for mortality due to CDH. This is the first risk factor study on CDH in the NICU from a developing country, namely China.
Patients and methods
This study was conducted at the NICU of the Children's Hospital, Zhejiang University School of Medicine. This hospital is a tertiary referral center with neonatal surgery services. The medical records of 38 CDH patients, admitted to the NICU between 1 January 1999 and 31 December 2008, were reviewed retrospectively. The study population was divided into two clinical groups: survivor group and non-survivor group. A flow diagram showing the course and outcome of all CDH patients enrolled in this study is presented in figure1. The institutional research ethics committee approved this study. Data on patient demographics, underlying disease, procedures, and medications were collected for analysis. CDH mortality was studied using multiple regression analysis of relevant factors: gestational age (GA), birth weight, the age at admission, sex, Apgar score, onset of respiratory distress, cardiac malformations, side of diaphragmatic hernia (left or right), air leak, presence of PPHN, preoperative respiratory management (conventional mechanical ventilation, CMV or HFOV), lung hypoplasia, the size of the diaphragmatic defect, the time of stabilization prior to surgery, profiles of postoperative respiratory care (highest oxygenation index, duration of mechanical ventilation) and closed thoracic drainage. The onset of respiratory distress was defined as the time of respiratory distress starting after delivery. Cardiac malformations were diagnosed by echocardiography. PPHN was defined as a preductal or postductal saturation difference greater than 10% and confirmed by echocardiography. The size of the diaphragmatic defect was determined by the surgeon at the time of repair. Stabilization was defined by the following criteria: (a) normal hemodynamic variables (mean blood pressure >40 mm Hg); (b) disappearance of the preductal or postductal saturation difference and signs of PPH on echocardiography without iNO; (c) a switch to CMV well tolerated with moderate values of peak inspiratory pressure (15-20 cmH2O ) and adequate oxygenation achieved with FiO2Ěҏ 0.4. OI was calculated with the following formula: (MAP×FiO2×100)/ postductal PaO2, where MAP was the mean airway pressure (in cmH2O), FiO2 was the fractional inspired oxygen, and PaO2 was the partial pressure of oxygen in arterial blood (in mmHg). Duration of mechanical ventilation was defined as the days of ventilation after surgery. The odds ratio (OR) associated with a given factor was an estimate of the risk for mortality of CDH when the factor was present relative to that when the factor was absent; 95% confidence intervals (95% CI) were used as a measure of the statistical precision of each odds ratio. 
Discussion
We performed a retrospective cohort study of CDH in NICU patients, controlling for underlying illness to measure risk factors for mortality and outcomes of CDH. To the best of our knowledge, few previous studies of this size, describing risk factors and outcomes of CDH in NICU patients, have been published in China According to various recent studies, the overall survive rate of CDH among patients in NICU ranges between 21% and 83%. (12) (13) (14) The apparently wide variation in mortality rates among different series was explained by "hidden mortality", because of failure to include those who remained highly unstable and died before transfer for surgery. In our study, we found a total survive rate of CDH in newborns to be 63.2% and the overall operative mortality was 20.0%. The survive rate of CDH in NICU appears, therefore, to be similar in comparison to recent studies in high-risk CDH patients, (6,13) but to be lower in comparison to some other studies in isolated CDH patients. (14, 15) In our study, we compared CDH patients who survived with non-survivors, and found that survivors were associated with an excess NICU length of stay.
This result suggests that CDH patients have a high mortality rate in early life. This may reflect the fact that survivors had less severe pulmonary hypoplasia and absence of lethal associated anomalies and that the combined degree of pulmonary hypoplasia and pulmonary hypertension determine the survival rate. (16, 17) Risk factors for CDH offer prognostic information about the probability of poor outcomes in CDH patients as well as help us to understand some of the mechanisms that may predispose to CDH. This may lead to development of effective prophylaxis and may allow risk stratification to target high risk patients for prevention strategies. There was significant difference in the age on admission, 5-minute Apgar score, onset of respiratory distress, cardiac malformations and presence of PPHN between CDH patients who survived and died. Using logistic regression analysis, only the age on admission and associated malformations was an independent risk factor for mortality. The age on admission, onset of respiratory distress and presence of PPHN were high-risk factors related to the severity of clinical characteristics in CDH patients, however, only the age on admission remained significant in the forward stepwise logistic regression model and we found that the age on admission increases the risk of death in CDH 8.15 fold. The median age on admission was 44.5hr in the survivors and 12.5hr in the non-survivors. This result suggests the more severe the clinical characteristics such as respiratory distress and the earlier the onset, the higher the mortality. Cardiac malformations have been described by previous investigators as risk factors for poor (24) However, in our study, we did not find any benefit of HFOV in CDH patients whether they underwent surgery or not. The reason for this finding was that we used HFOV as a rescue mode and these CDH patients were supported with HFOV when conventional ventilation was ineffective. Thus, when used as the initial mode of therapy, HFOV may be a more effective mode of ventilation support than conventional ventilation. In summary, we performed a retrospective cohort study to determine survive rates, risk factors, and outcomes of CDH in a NICU. We found a relatively high mortality rate of CDH and identified independent predictors for mortality of CDH, including the age on admission and cardiac malformations. Studies of interventions to decrease the mortality of CDH are needed in NICU patients. However, the sample size and the small number of events per group, as well as retrospective study design, substantially limit our conclusions. In order to confirm these conclusions, a large and prospective randomized controlled trial is mandatory and studies of interventions such as pre-and postoperative respiratory management; rescue ventilator strategies and the effect of timing of surgery might be achievable.
